What better way to start the New Year than by diving into the fascinating world of CRISPR and organoids? Join the organoid@KUL community for an insightful session with two leading experts who will demonstrate how to leverage CRISPR technology to address critical research questions in human diseases modeled using organoids. Maarten Geurts employs CRISPR technology to explore - amongst others - the role of specific gut epithelial cells in detecting intestinal contents, shedding light on physiological processes such as appetite regulation, bowel movements, and insulin sensitivity. Read more here (https://lnkd.in/esDG3-Qe). Julian Grünewald has made significant contributions to the CRISPR field, including the development of prime editors with compact, untethered reverse transcriptases (https://lnkd.in/e9pT8gaW) and base editors with reduced RNA off-target effects (https://lnkd.in/eQvunVsG). His recent work focuses on modeling and treating cardiac diseases using CRISPR. Don't miss this opportunity to learn from these experts on 7 January 2025, at 1 PM, KU Leuven, campus Gasthuisberg. All welcome!
PhD Researcher at Laboratory for Molecular Virology & Gene Therapy | FWO-SB Fellow | Cystic Fibrosis researcher | 🧬CRISPR enthusiast!
To all fellow Science enthusiasts: You are cordially invited to our #organoid x #CRISPR #minisymposium🧫🧬! We are pleased to feature two absolute rockstar speakers🎸: dr. Julian Grünewald and dr. Maarten Geurts! Feel free to join us January 7, 1PM @Gasthuisberg ON1, auditorium GA3, Leuven. This event is free for all to attend and brought to you by KU Leuven laboratories Molecular Medicine KU Leuven and BREATHE lab KU Leuven. Hope to see you there! Calender invitation: https://lnkd.in/eV36BDc2